Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Debt / NOTE 2.000% 3/1
-
Market price (% of par)
-
93.11%
-
Total 13F principal
-
$310,090,000
-
Principal change
-
-$10,100,500
-
Total reported market value
-
$290,929,251
-
Number of holders
-
36
-
Value change
-
-$11,266,815
-
Number of buys
-
17
-
Number of sells
-
21
Institutional Holders of AMPHASTAR PHARMACEUTICALS IN - NOTE 2.000% 3/1 as of Q4 2024
As of 31 Dec 2024,
AMPHASTAR PHARMACEUTICALS IN - NOTE 2.000% 3/1 was held by
36 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$310,090,000
in principal (par value) of the bond.
The largest 10 bondholders included
Linden Advisors LP, MACKAY SHIELDS LLC, READYSTATE ASSET MANAGEMENT LP, CAMDEN ASSET MANAGEMENT L P /CA, Wellesley Asset Management, BRAIDWELL LP, Empyrean Capital Partners, LP, SHENKMAN CAPITAL MANAGEMENT INC, Calamos Advisors LLC, and WOLVERINE ASSET MANAGEMENT LLC.
This page lists
36
institutional bondholders reporting positions
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.